191 related articles for article (PubMed ID: 25010042)
1. Antiviral lectins as potential HIV microbicides.
Koharudin LM; Gronenborn AM
Curr Opin Virol; 2014 Aug; 7():95-100. PubMed ID: 25010042
[TBL] [Abstract][Full Text] [Related]
2. GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors.
Zhou R; Wang X; Liu H; Guo L; Su Q; Wang H; Vasiliadis T; Ho W; Li J
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263266
[TBL] [Abstract][Full Text] [Related]
3. Algal lectins as potential HIV microbicide candidates.
Huskens D; Schols D
Mar Drugs; 2012 Jul; 10(7):1476-1497. PubMed ID: 22851920
[TBL] [Abstract][Full Text] [Related]
4. The characteristic structure of anti-HIV actinohivin in complex with three HMTG D1 chains of HIV-gp120.
Zhang F; Hoque MM; Jiang J; Suzuki K; Tsunoda M; Takeda Y; Ito Y; Kawai G; Tanaka H; Takénaka A
Chembiochem; 2014 Dec; 15(18):2766-73. PubMed ID: 25403811
[TBL] [Abstract][Full Text] [Related]
5. Binding Site Geometry and Subdomain Valency Control Effects of Neutralizing Lectins on HIV-1 Viral Particles.
Lusvarghi S; Lohith K; Morin-Leisk J; Ghirlando R; Hinshaw JE; Bewley CA
ACS Infect Dis; 2016 Nov; 2(11):882-891. PubMed ID: 27669574
[TBL] [Abstract][Full Text] [Related]
6. [Carbohydrate-binding proteins of marine invertebrates].
Luk'ianov PA; Chernikov OV; Kobelev SS; Chikalovets IV; Molchanova VI; Li W
Bioorg Khim; 2007; 33(1):172-81. PubMed ID: 17375673
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents.
Petrova MI; Mathys L; Lebeer S; Noppen S; Van Damme EJ; Tanaka H; Igarashi Y; Vaneechoutte M; Vanderleyden J; Balzarini J
J Antimicrob Chemother; 2013 Sep; 68(9):2026-37. PubMed ID: 23640125
[TBL] [Abstract][Full Text] [Related]
8. Mechanism by which the lectin actinohivin blocks HIV infection of target cells.
Tanaka H; Chiba H; Inokoshi J; Kuno A; Sugai T; Takahashi A; Ito Y; Tsunoda M; Suzuki K; Takénaka A; Sekiguchi T; Umeyama H; Hirabayashi J; Omura S
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15633-8. PubMed ID: 19717426
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV entry by carbohydrate-binding proteins.
Balzarini J
Antiviral Res; 2006 Sep; 71(2-3):237-47. PubMed ID: 16569440
[TBL] [Abstract][Full Text] [Related]
10. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
[TBL] [Abstract][Full Text] [Related]
11. Broad anti-HIV activity of the Oscillatoria agardhii agglutinin homologue lectin family.
Férir G; Huskens D; Noppen S; Koharudin LM; Gronenborn AM; Schols D
J Antimicrob Chemother; 2014 Oct; 69(10):2746-58. PubMed ID: 24970741
[TBL] [Abstract][Full Text] [Related]
12. Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.
Jay JI; Lai BE; Myszka DG; Mahalingam A; Langheinrich K; Katz DF; Kiser PF
Mol Pharm; 2010 Feb; 7(1):116-29. PubMed ID: 20014858
[TBL] [Abstract][Full Text] [Related]
13. High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.
Hirayama M; Shibata H; Imamura K; Sakaguchi T; Hori K
Mar Biotechnol (NY); 2016 Apr; 18(2):215-31. PubMed ID: 26661793
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
[TBL] [Abstract][Full Text] [Related]
15. Structural studies of algal lectins with anti-HIV activity.
Ziółkowska NE; Wlodawer A
Acta Biochim Pol; 2006; 53(4):617-26. PubMed ID: 17128290
[TBL] [Abstract][Full Text] [Related]
16. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
17. Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy.
Flores A; Quesada E
Curr Med Chem; 2013 Feb; 20(6):751-71. PubMed ID: 23278399
[TBL] [Abstract][Full Text] [Related]
18. The antiviral lectin cyanovirin-N: probing multivalency and glycan recognition through experimental and computational approaches.
Woodrum BW; Maxwell JD; Bolia A; Ozkan SB; Ghirlanda G
Biochem Soc Trans; 2013 Oct; 41(5):1170-6. PubMed ID: 24059504
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120: a new therapeutic concept to hit the achilles heel of HIV.
Balzarini J; Van Laethem K; Hatse S; Froeyen M; Peumans W; Van Damme E; Schols D
J Biol Chem; 2005 Dec; 280(49):41005-14. PubMed ID: 16183648
[TBL] [Abstract][Full Text] [Related]
20. Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.
Balzarini J; Van Laethem K; Daelemans D; Hatse S; Bugatti A; Rusnati M; Igarashi Y; Oki T; Schols D
J Virol; 2007 Jan; 81(1):362-73. PubMed ID: 17050611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
